title: Fiber pathway pathology, synapse loss and decline of cortical function in schizophrenia.
abstract: A quantitative cortical model is developed, based on both computational and simulation approaches, which relates measured changes in cortical activity of gray matter with changes in the integrity of longitudinal fiber pathways. The model consists of modules of up to 5,000 neurons each, 80% excitatory and 20% inhibitory, with these having different degrees of synaptic connectiveness both within a module as well as between modules. It is shown that if the inter-modular synaptic connections are reduced to zero while maintaining the intra-modular synaptic connections constant, then activity in the modules is reduced by about 50%. This agrees with experimental observations in which cortical electrical activity in a region of interest, measured using the rate of oxidative glucose metabolism (CMRglc(ox)), is reduced by about 50% when the cortical region is isolated, either by surgical means or by transient cold block. There is also a 50% decrease in measured cortical activity following inactivation of the nucleus of Meynert and the intra-laminar nuclei of the thalamus, which arise either following appropriate lesions or in sleep. This occurs in the model if the inter-modular synaptic connections require input from these nuclei in order to function. In schizophrenia there is a 24% decrease in functional anisotropy of longitudinal fasciculi accompanied by a 7% decrease in cortical activity (CMRglc(ox)).The cortical model predicts this, namely for a 24% decrease in the functioning of the inter-modular connections, either through the complete loss of 24% of axons subserving the connections or due to such a decrease in the efficacy of all the inter-modular connections, there will be about a 7% decrease in the activity of the modules. This work suggests that deterioration of longitudinal fasciculi in schizophrenia explains the loss of activity in the gray matter.
authors.affiliation: The Brain and Mind Research Institute, University of Sydney, Sydney, NSW, Australia. max.bennett@sydney.edu.au
authors.forename: Max R
authors.initials: MR
authors.lastname: Bennett
authors.forename: Les
authors.initials: L
authors.lastname: Farnell
authors.forename: William G
authors.initials: WG
authors.lastname: Gibson
mesh_terms: D000818:Animals; D002540:Cerebral Cortex / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008959:Models, Neurological; D009412:Nerve Fibers / Q000473:pathology*; D009415:Nerve Net / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D010084:Oxidation-Reduction; D051381:Rats; D012559:Schizophrenia / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology*; D013569:Synapses / Q000473:pathology*
chemical_list: D005947:Glucose